David Malcom Rodman, Chief Medical Officer: Mineralys Therapeutics MLYS Sell · Filed 03/16

Trade details

Type: Insider sale
Amount: $277,910.66
Shares · price: 10,726 sh · $25.91 a share
Held after: 79,472 sh
Stock: Mineralys Therapeutics MLYS
Person: David Malcom RodmanChief Medical Officer
Trade date: 26/03/13
Filed: 26/03/16
Days to filing: 3 days

Sold 11.9% of holdings

Share of holding sold: 11.9%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 02/11~04/12

David Malcom Rodman's recent trades

David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$11.7K
417 sh
$11.7K
Filed 09/17
Traded 09/17
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$216.9K
7,709 sh
$216.9K
Filed 09/14
Traded 09/14
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$67K
2,171 sh
$67K
Filed 09/09
Traded 09/09
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$10.6K
417 sh
$10.6K
Filed 08/17
Traded 08/17
David Malcom RodmanChief Medical Officer
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$372.2K
14,056 sh
$372.2K
Filed 08/13
Traded 08/13

David Malcom Rodman, Chief Officer — sold $277.9K of Mineralys Therapeutics MLYS · 11.9% of holdings · 10b5-1 plan | Whalegun